Assembly Biosciences, Inc. (ASMB) Free cash flow 2016–2025
Assembly Biosciences, Inc. (ASMB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$41.2MFY2025 · since FY2016: -$35.0M → -$41.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.2M | +19.5% |
| FY2024 | -$51.1M | -327.4% |
| FY2023 | $22.5M | +126.6% |
| FY2022 | -$84.6M | +12.4% |
| FY2021 | -$96.5M | -52.1% |
| FY2020 | -$63.4M | +25.9% |
| FY2019 | -$85.6M | -31.1% |
| FY2018 | -$65.3M | -6662.6% |
| FY2017 | $995,000 | +102.8% |
| FY2016 | -$35.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ASMB financial trends
ASMB RevenueASMB Net incomeASMB Net marginASMB Gross profitASMB Gross marginASMB Operating incomeASMB Operating marginASMB Operating cash flowASMB Capital expendituresASMB Return on equityASMB Stock buybacksASMB Dividends paidASMB Total assetsASMB Total liabilitiesASMB Shareholders’ equityASMB overview →